DIAGNOS Inc. announced a strategic partnership with EssilorLuxottica. This exclusive distribution agreement for Canada, signed on December 6th, signals a monumental leap for DIAGNOS, solidifying its standing as a premier provider of cutting-edge retinal analysis technology. DIAGNOS' AI-powered retinal image analysis technology has gained widespread acclaim in numerous countries, delivering invaluable benefits to eye health.

This solution facilitates early detection of various eye conditions, thereby enhancing the quality of eye health care and positively impacting the lives of patients. The exclusive distribution agreement with EssilorLuxotica, set for an initial term of three years with the possibility of renewal, exemplifies the enduring commitment of both companies to advancing eye health and cutting-edge technology. As per the agreement, DIAGNOS will be paid on a per patient exam basis throughout EssilorLuxottic network of clients.

DIAGNOS and EssilorLuxottico are poised to collaborate closely, offering innovative solutions to optometrists that will revolutionize the early detection of eye problems and elevate the quality of eye care in the region under the agreement.